Rocket Lab Clears HSR, Files S-4 and FCC Applications for Iridium Acquisition
IRDM has more than doubled off its 52-week low of $15.645.
Summary
Rocket Lab cleared U.S. antitrust review, filed its S-4 and FCC applications, and outlined financing plans for its acquisition of Iridium.
Key Events · M&A and Partnerships · IRDM
-
HSR Waiting Period Expired
The U.S. antitrust waiting period under HSR expired at 11:59 p.m. ET on August 12, 2026, clearing a major regulatory hurdle for the acquisition.
-
Form S-4 Filed with SEC
Rocket Lab filed its registration statement on Form S-4 on August 13, 2026, to register the shares to be issued to Iridium shareholders.
-
FCC Applications Filed
Rocket Lab and Iridium filed applications with the FCC on August 10, 2026, seeking consent to transfer control of Iridium's licenses.
-
Financing Strategy Update
Rocket Lab announced a new at-the-market equity program and plans to amend Iridium's $1.775 billion term loan to reduce reliance on the $3.6 billion bridge facility.
Analysis · IRDM · Technology
A major antitrust hurdle has been cleared: the HSR waiting period for Rocket Lab's acquisition of Iridium expired on August 12, 2026. The company also filed its Form S-4 registration statement with the SEC and FCC applications to transfer Iridium's licenses. These are critical steps toward closing the $54 per share deal. Additionally, Rocket Lab disclosed a new at-the-market equity program and plans to amend Iridium's $1.775 billion term loan to reduce reliance on a $3.6 billion bridge facility. The regulatory clearances and financing strategy reduce deal risk and clarify the path to completion.
At the time of this filing, IRDM was trading at $49.90 on NASDAQ in the Technology sector, with a market capitalization of approximately $5.3B. The 52-week trading range was $15.65 to $57.18. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.